Cargando…
18333 Utilizing community engagement approaches in translational research
ABSTRACT IMPACT: Leverage community engagement to continue moving translational science and research forward. OBJECTIVES/GOALS: Engaging community in translational research improves innovation and speeds the movement of evidence into practice. Yet, it is unclear how community is engaged across the t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827778/ http://dx.doi.org/10.1017/cts.2021.595 |
_version_ | 1784647709985079296 |
---|---|
author | King, Keyonna M. Estabrooks, Paul Tchouankam, Tatiana Keeler, Heidi Palm, David Love, Kenya Minter, Christian I.J. Watanabe-Galloway, Shinobu Navarrette, Sean Teel-Williams, Maria |
author_facet | King, Keyonna M. Estabrooks, Paul Tchouankam, Tatiana Keeler, Heidi Palm, David Love, Kenya Minter, Christian I.J. Watanabe-Galloway, Shinobu Navarrette, Sean Teel-Williams, Maria |
author_sort | King, Keyonna M. |
collection | PubMed |
description | ABSTRACT IMPACT: Leverage community engagement to continue moving translational science and research forward. OBJECTIVES/GOALS: Engaging community in translational research improves innovation and speeds the movement of evidence into practice. Yet, it is unclear how community is engaged across the translational research spectrum or the degree of community-engagement used. We conducted a scoping review to fill this gap. METHODS/STUDY POPULATION: We used the PRISMA model search strategy with a range of databases (e.g., PubMed/Medline, Scopus) to identify articles published between January 2008 and November 2018 (n=167) and eliminated studies that did not use any level of community-engagement (n=102). Studies were coded for translational stage-corresponding to T0 (basic science), T1 (basic science to clinical research in humans; n=6), T2 (clinical efficacy and effectiveness research, n=45), T3 (dissemination and implementation research, n=95), and T4 (population health, n=21) as well as the degree of community engagement from least to most intensive (i.e., outreach, consultation, involvement, collaboration, shared leadership). RESULTS/ANTICIPATED RESULTS: The final number of eligible articles was 65. There was a relatively balanced distribution across levels of community engagement across articles (i.e., outreach, n=14; consultation, n=13; involvement, n=7; collaboration, n=15; shared leadership, n=16). Within these articles, the depth of community engagement varied with higher engagement typically occurring at later stages of translational research (T3 and T4), but more specifically in the dissemination and implementation science stage (T3). However, shared leadership, the most intensive form of engagement, was found in T2, T3, and T4 studies suggesting the value of community-engagement across the translational research spectrum. DISCUSSION/SIGNIFICANCE OF FINDINGS: A strong understanding of how various levels of community engagement are used in translational research, and the outcomes they produce, may to expedite the translation of knowledge into practice and enable practice-based needs to inform policy. |
format | Online Article Text |
id | pubmed-8827778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88277782022-02-28 18333 Utilizing community engagement approaches in translational research King, Keyonna M. Estabrooks, Paul Tchouankam, Tatiana Keeler, Heidi Palm, David Love, Kenya Minter, Christian I.J. Watanabe-Galloway, Shinobu Navarrette, Sean Teel-Williams, Maria J Clin Transl Sci Health Equity & Community Engagement ABSTRACT IMPACT: Leverage community engagement to continue moving translational science and research forward. OBJECTIVES/GOALS: Engaging community in translational research improves innovation and speeds the movement of evidence into practice. Yet, it is unclear how community is engaged across the translational research spectrum or the degree of community-engagement used. We conducted a scoping review to fill this gap. METHODS/STUDY POPULATION: We used the PRISMA model search strategy with a range of databases (e.g., PubMed/Medline, Scopus) to identify articles published between January 2008 and November 2018 (n=167) and eliminated studies that did not use any level of community-engagement (n=102). Studies were coded for translational stage-corresponding to T0 (basic science), T1 (basic science to clinical research in humans; n=6), T2 (clinical efficacy and effectiveness research, n=45), T3 (dissemination and implementation research, n=95), and T4 (population health, n=21) as well as the degree of community engagement from least to most intensive (i.e., outreach, consultation, involvement, collaboration, shared leadership). RESULTS/ANTICIPATED RESULTS: The final number of eligible articles was 65. There was a relatively balanced distribution across levels of community engagement across articles (i.e., outreach, n=14; consultation, n=13; involvement, n=7; collaboration, n=15; shared leadership, n=16). Within these articles, the depth of community engagement varied with higher engagement typically occurring at later stages of translational research (T3 and T4), but more specifically in the dissemination and implementation science stage (T3). However, shared leadership, the most intensive form of engagement, was found in T2, T3, and T4 studies suggesting the value of community-engagement across the translational research spectrum. DISCUSSION/SIGNIFICANCE OF FINDINGS: A strong understanding of how various levels of community engagement are used in translational research, and the outcomes they produce, may to expedite the translation of knowledge into practice and enable practice-based needs to inform policy. Cambridge University Press 2021-03-30 /pmc/articles/PMC8827778/ http://dx.doi.org/10.1017/cts.2021.595 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Health Equity & Community Engagement King, Keyonna M. Estabrooks, Paul Tchouankam, Tatiana Keeler, Heidi Palm, David Love, Kenya Minter, Christian I.J. Watanabe-Galloway, Shinobu Navarrette, Sean Teel-Williams, Maria 18333 Utilizing community engagement approaches in translational research |
title | 18333 Utilizing community engagement approaches in translational research |
title_full | 18333 Utilizing community engagement approaches in translational research |
title_fullStr | 18333 Utilizing community engagement approaches in translational research |
title_full_unstemmed | 18333 Utilizing community engagement approaches in translational research |
title_short | 18333 Utilizing community engagement approaches in translational research |
title_sort | 18333 utilizing community engagement approaches in translational research |
topic | Health Equity & Community Engagement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827778/ http://dx.doi.org/10.1017/cts.2021.595 |
work_keys_str_mv | AT kingkeyonnam 18333utilizingcommunityengagementapproachesintranslationalresearch AT estabrookspaul 18333utilizingcommunityengagementapproachesintranslationalresearch AT tchouankamtatiana 18333utilizingcommunityengagementapproachesintranslationalresearch AT keelerheidi 18333utilizingcommunityengagementapproachesintranslationalresearch AT palmdavid 18333utilizingcommunityengagementapproachesintranslationalresearch AT lovekenya 18333utilizingcommunityengagementapproachesintranslationalresearch AT minterchristianij 18333utilizingcommunityengagementapproachesintranslationalresearch AT watanabegallowayshinobu 18333utilizingcommunityengagementapproachesintranslationalresearch AT navarrettesean 18333utilizingcommunityengagementapproachesintranslationalresearch AT teelwilliamsmaria 18333utilizingcommunityengagementapproachesintranslationalresearch |